510(k) Report

510(k) · Cleared

Cleared

Redemption Duo Hindfoot Nail System

K231343510(k) TraditionalCleared Jan 30, 2024266-day reviewClass II21 CFR 888.3020

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Vilex, LLC · HSB Rod, Fixation, Intramedullary And Accessories

Cleared on Jan 30, 2024 as substantially equivalent to K091976 (Biomet Trauma, 2009) after a 266-day review. Its family tree reaches back 1 generation to 2009. 1 later device descends from it.

Decided
Jan 30, 2024
Review
266 days
Class
Class II
Product code
HSB
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to K091976 (2009). 1 later device descends from it, 1 citing it directly.

Descendants, by generation 1 generation forward: 1 descendant K091976 · Biomet Phoenix Ankle Nail and Ankle Arthrodesis Nail · Biomet Trauma · 2009 · recalled0
  1. Root · 1 generation backK091976 Biomet Phoenix Ankle Nail and Ankle Arthrodesis NailBiomet Trauma · 2009 · Recalled
  2. This deviceK231343 Redemption Duo Hindfoot Nail SystemVilex, LLC · 2024
  3. Descendant · cites it directly · 0 of its ownK260900 DYNEX® External Fixation SystemsVilex, LLC · 2026

Most influential descendants

Showing 1 of 1 · See all
  • K260900DYNEX® External Fixation SystemsVilex, LLC · 2026 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K091976Biomet Phoenix Ankle Nail and Ankle Arthrodesis NailBiomet Trauma20092
0 (this device)K231343Redemption Duo Hindfoot Nail SystemVilex, LLC2024—
+1K260900DYNEX® External Fixation SystemsVilex, LLC2026—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
202610
FIG. 1 — Lineage of K231343, 2009–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in HSB? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new HSB device

  1. #1 K200869 Gamma3 Systemscore 19.8 · 8 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K091976Biomet Phoenix Ankle Nail and Ankle Arthrodesis Nail
Summary page 4
…ion Duo Hindfoot Nail System Vilex HSB Device Primary Biomet Phoenix Ankle Nail and Ankle Zimmer K091976 HSB Predicate Arthrodesis Nail…
Biomet Trauma20092
†K221031Arthrex DualCompression Hindfoot Fusion Nail Implant SystemArthrex, Inc.2022—
†K051678Synthes Hindfoot Arthrodesis Nail SystemSynthes (Usa)20051
†K173811TRIWAY Tibiotalocalcaneal (TTC) Arthrodesis SystemIn2bones Sas2018—
†K102413Fuze: Intramedullary Internal Fixation NailVilex, Inc.20113

Also cleared against K091976: 5 other devices →

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K260900DYNEX® External Fixation SystemsVilex, LLC20260

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has a recall.
  • Of its descendants, K260900 (Vilex, LLC, 2026) has gone furthest, with 0 descendants of its own.
  • 5 other devices also cite its predicate K091976.

How does its category compare?

All HSB devices

HSB Rod, Fixation, Intramedullary And Accessories: FDA decisions, review times, recalls and adverse event reports over 20 years. 2024, this device’s year, is highlighted.

FDA decisions per year · HSB

15in 2025

2007: 82008: 112009: 182010: 142011: 162012: 172013: 182014: 192015: 222016: 82017: 232018: 172019: 132020: 172021: 102022: 122023: 112024: 132025: 152026 (partial year): 18
2007high 23 (2017) · low 8 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · HSB

106in 2025

2007: 68 days median2008: 57 days median2009: 86 days median2010: 117 days median2011: 78 days median2012: 112 days median2013: 105 days median2014: 147 days median2015: 111 days median2016: 124 days median2017: 119 days median2018: 134 days median2019: 132 days median2020: 112 days median2021: 94 days median2022: 172 days median2023: 162 days median2024: 195 days median2025: 106 days median2026 (partial year): 151 days median
2007high 195 (2024) · low 57 (2008)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · HSB

18in 2025

2008: 92009: 812010: 182011: 22012: 72013: 142014: 32015: 32016: 62017: 662018: 562019: 62020: 62021: 22022: 12023: 12024: 12025: 182026 (partial year): 1
2007high 81 (2009) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · HSB

2,911in 2025

2007: 1622008: 1842009: 3342010: 4542011: 6622012: 1,0792013: 1,7732014: 1,4742015: 1,6712016: 1,9202017: 1,4472018: 3,5262019: 2,5172020: 3,2992021: 4,1112022: 2,7332023: 2,2192024: 2,8692025: 2,911
2007high 4,111 (2021) · low 162 (2007)2025

MAUDE reports naming product code HSB, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20078680162
200811579184
2009188681334
20101411718454
201116782662
20121711271,079
201318105141,773
20141914731,474
20152211131,671
2016812461,920
201723119661,447
201817134563,526
20191313262,517
20201711263,299
2021109424,111
20221217212,733
20231116212,219
20241319512,869
202515106182,911
2026181511—

What is it indicated for?

The Vilex Redemption Duo Hindfoot Nail System is intended for tibiotalocalcaneal arthrodesis (fusion) Specific indications include: • Post-traumatic or degenerative arthritis • Previously infected arthrosis • Revision ankle arthrodesis • Failed total ankle arthroplasty • Avascular necrosis of the talus • Severe deformity or instability as a result of talipes equinovarus, cerebral vascular accident, paralysis or other neuromuscular disease • Rheumatoid…

Read the full statement (94 words)

The Vilex Redemption Duo Hindfoot Nail System is intended for tibiotalocalcaneal arthrodesis (fusion)

Specific indications include:

• Post-traumatic or degenerative arthritis

• Previously infected arthrosis

• Revision ankle arthrodesis

• Failed total ankle arthroplasty

• Avascular necrosis of the talus

• Severe deformity or instability as a result of talipes equinovarus, cerebral vascular accident, paralysis or other neuromuscular disease

• Rheumatoid arthritis

• Osteoarthritis

• Pseudarthrosis

• Trauma (malunited tibial pilon fracture)

• Charcot foot

• Severe endstage degenerative arthritis

• Severe defects after tumor resection

• Pantalar arthrodesis

• Post-traumatic arthrosis

• Neuroarthropathy

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K231343: Redemption Duo Hindfoot Nail System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K231343

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026